FMC Corporation, a key player in the agrochemical industry, has been involved in a flurry of activities. Notable among these is the disclosure of
$330,000 lobbying expenditure and the
approval of Tremisia fungicide in Ukraine opening up the EMEA market. The corporation has repeatedly declared
quarterly dividends, a recent one being 58 cents per share, and its agtech VC arm,
FMC Ventures, has been restructured to optimize operations. Its recent earning trajectories have caused speculation about its potential as a good long-term investment. Analysts see an estimated
10.61% upside in its shares and a GF Value estimate of 57.13%. However, its
stock has tumbled following a
33% fall in value after inventory destocking continues. FMC also stands accused of misleading investors about sales and inventory. More positively, its Fluindapyr fungicide is seen as a strategic play for dominance in EMEA and it has been named as a
2025 CIO 100 award winner for Arc™ farm intelligence. Overall, the firm has shown both promising progress and significant challenges recently.
Fmc Corporation FMC News Analytics from Thu, 17 Oct 2024 07:00:00 GMT to Sat, 19 Jul 2025 15:38:37 GMT -
Rating 5
- Innovation 4
- Information 7
- Rumor 1
